Raymond James & Associates’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $170K | Hold |
85,463
| – | – | ﹤0.01% | 3654 |
|
|
2024
Q2 | $299K | Sell |
85,463
-2,057
| -2% | -$7.2K | ﹤0.01% | 3350 |
|
|
2024
Q1 | $242K | Buy |
+87,520
| New | +$242K | ﹤0.01% | 3477 |
|
|
2021
Q4 | – | Sell |
-14,081
| Closed | -$151K | – | 4021 |
|
|
2021
Q3 | $151K | Buy |
+14,081
| New | +$151K | ﹤0.01% | 3707 |
|
|
2021
Q2 | – | Sell |
-45,788
| Closed | -$742K | – | 3937 |
|
|
2021
Q1 | $742K | Buy |
45,788
+36,224
| +379% | +$587K | ﹤0.01% | 2706 |
|
|
2020
Q4 | $202K | Buy |
+9,564
| New | +$202K | ﹤0.01% | 3360 |
|
|
2020
Q3 | – | Sell |
-11,684
| Closed | -$172K | – | 3497 |
|
|
2020
Q2 | $172K | Buy |
11,684
+893
| +8% | +$13.1K | ﹤0.01% | 3152 |
|
|
2020
Q1 | $127K | Sell |
10,791
-591
| -5% | -$6.96K | ﹤0.01% | 3141 |
|
|
2019
Q4 | $267K | Sell |
11,382
-3,460
| -23% | -$81.2K | ﹤0.01% | 3134 |
|
|
2019
Q3 | $275K | Sell |
14,842
-16,461
| -53% | -$305K | ﹤0.01% | 3054 |
|
|
2019
Q2 | $582K | Buy |
31,303
+6,448
| +26% | +$120K | ﹤0.01% | 2546 |
|
|
2019
Q1 | $607K | Buy |
24,855
+1,250
| +5% | +$30.5K | ﹤0.01% | 2525 |
|
|
2018
Q4 | $612K | Sell |
23,605
-2,522
| -10% | -$65.4K | ﹤0.01% | 2409 |
|
|
2018
Q3 | $827K | Sell |
26,127
-2,982
| -10% | -$94.4K | ﹤0.01% | 2370 |
|
|
2018
Q2 | $1.13M | Buy |
29,109
+165
| +0.6% | +$6.41K | ﹤0.01% | 2112 |
|
|
2018
Q1 | $799K | Buy |
+28,944
| New | +$799K | ﹤0.01% | 2276 |
|